Wednesday, June 10, 2026
🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
2,004

Quick answer

2,004 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7067635

    Nucleotide and deduced amino acid sequences of tumor gene Int6

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7067109

    Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7067653

    Porphyrin Based neuton capture agents for cancer therapy

    The Regents of the University of California · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7056908

    Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7056503

    Enclosures housing cell-coated supports for treating tumors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7053263

    Mouse models of human prostate cancer progression

    The Regents of the University of California · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7029652

    Method of treating tumors

    The Regents of the University of California · Granted Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 7005424

    Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

    The Board of Regents of the University of Texas System · Granted Tue Feb 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 7001600

    Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6998513

    Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use

    The Regents of the University of California · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6998117

    Cancer treatment with retroviral vectors comprising wild-type p53

    The Board of Regents of the University of Texas System · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6998413

    Treatment of neoplasms with yujungamycins

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6995188

    S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

    The Board of Regents of the University of Texas System · Granted Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6987193

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6986891

    Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof

    Molecular Discoveries, L.L.C. · Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6984522

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6984619

    Method for protection against tumor metastasis formation

    The Board of Regents of the University of Texas System · Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6982168

    Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6979563

    Attenuation of tumor growth, metastasis and angiogenesis

    BioMarin Enzymes, Inc. · Granted Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6965017

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6960443

    Methods of detecting prostate stem cell antigen in cancer

    The Regents of the University of California · Granted Tue Nov 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6956145

    Mice models of human prostate cancer progression

    The Regents of the University of California · Granted Tue Oct 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6951917

    MHC-class II restricted melanoma antigens and their use in therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6949690

    Methods of assessing the effect of a gene of interest on human prostate cancer progression

    The Regents of the University of California · Granted Tue Sep 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6943245

    Tumor suppressor CAR-1

    The Board of Regents of the University of Texas System · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6929802

    Method of cancer treatment

    The Board of Regents of the University of Texas System · Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6929910

    Diagnostic and therapeutic methods using the H37 tumor suppressor gene

    The Regents of the University of California · Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6924095

    Retrovirus isolated from mantle histiocytes in mantle cell lymphoma

    The Regents of the University of California · Granted Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6921765

    1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors

    APREA AB · Granted Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6919425

    Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery

    The Board of Regents of the University of Texas System · Granted Tue Jul 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6911471

    S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

    The Board of Regents of the University of Texas System · Granted Tue Jun 28 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6908918

    Antitumor agents

    The Regents of the University of California · Granted Tue Jun 21 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6897018

    DLC-1 gene deleted in cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6897316

    Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents

    China Medical University · Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6894026

    Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders

    Atossa Healthcare, Inc. · Granted Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6890917

    Geldanamycin derivative and method of treating cancer using same

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 10 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6884414

    Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

    The United State of America as represented by the Department of Health and Human Services · Granted Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6881420

    Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6869604

    Recombinant anti-tumor RNAse

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6869924

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6864066

    Epithelial protein lost in neoplasm (EPLIN)

    The Regents of the University of California · Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6863887

    Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

    Northwest Biotherapeutics, Inc. · Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6855696

    Antitumor agents

    The Regents of the University of California · Granted Tue Feb 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6849417

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6838081

    Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient

    The Regents of the University of California · Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6828471

    Mice models of human prostate cancer

    The Regents of the University of California · Granted Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6825186

    Method and compositions for treating atheroma, tumors and other neoplastic tissue

    The Board of Regents of the University of Texas System · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6821522

    Tumor Therapy

    The Regents of the University of California · Granted Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

2,004 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.